Möchten Sie immer auf dem neuesten Stand bleiben?

Cambridge, Massachusetts, July 27, 2026 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing antibody therapeutics and vaccines targeting...

Dr. Zack brings more than 25 years of leadership in developing therapeutics for immune-mediated diseasesAppointment strengthens Spero’s clinical leadership team as the Company advances SP001, a Phase...

SAN DIEGO, July 16, 2026 (GLOBE NEWSWIRE) -- Gyre Therapeutics, Inc. (“Gyre”, “Gyre Therapeutics” or the “Company”) (Nasdaq: GYRE), an innovative, commercial-stage biopharmaceutical company with...

CAMBRIDGE, Mass., July 15, 2026 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced the appointment of Michael J. Parini as Chief Legal Officer, effective August 3, 2026. Parini will...

Under the terms of the agreement, Spero will receive exclusive global rights, excluding Greater China, to develop, research, manufacture, and commercialize SP001 (IBI355) Innovent will receive an...

Dublin, July 13, 2026 (GLOBE NEWSWIRE) -- The "Liabilities, Damages and other Contentious Issues in International Commercial Agreements (London, United Kingdom - Nov 11th - Nov 12th, 2026)" has been...

– Seasoned executive brings extensive leadership experience spanning corporate development, business development and pipeline strategy – – Track record includes helping build and advance leading...

Diranersen presentation will feature Phase 2 CELIA data in early Alzheimer’s disease, including clinical, biomarker and safety results for Biogen’s investigational tau-targeting ASO, following topline...

AUSTIN, Texas, June 15, 2026 (GLOBE NEWSWIRE) -- AINewsWire Editorial Coverage: The global race to build artificial intelligence infrastructure has triggered a capital spending surge unlike anything...

Leading CISOs honored for leadership, enterprise security, and business impact at the BostonCISO ORBIE Awards on June 11, 2026.